Immunosuppressant and SARS-CoV-2 Vaccine Antibody Response After Lung Transplantation

BACKGROUND: There are insufficient reports on the immunogenicity and safety of the COVID-19 vaccination after lung transplantation in Korea. METHODS: Between April and September 2021, lung transplant recipients (n = 52) and healthy controls (n = 22) underwent vaccination. The levels of antibodies we...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Hye-Jin, Lee, Hyun Ji, Yu, Shinae, Shin, Kyung-Hwa, Cho, Woo Hyun, Yeo, Hye Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Inc. 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663737/
https://www.ncbi.nlm.nih.gov/pubmed/36411096
http://dx.doi.org/10.1016/j.transproceed.2022.11.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9663737/
https://www.ncbi.nlm.nih.gov/pubmed/36411096
http://dx.doi.org/10.1016/j.transproceed.2022.11.001

Ejemplares similares